» Articles » PMID: 12135539

Emotional Blunting Associated with SSRI-induced Sexual Dysfunction. Do SSRIs Inhibit Emotional Responses?

Overview
Specialty Psychiatry
Date 2002 Jul 24
PMID 12135539
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Anecdotal and published case reports suggest that some patients taking selective serotonin reuptake inhibitors (SSRI) experience diminution in emotional responsiveness. This study aims to define the individual components of emotion disturbed in these patients. Fifteen patients reporting SSRI-induced sexual dysfunction completed the Laukes Emotional Intensity Scale (LEIS), a questionnaire about various emotions. Compared to controls, patients reported significantly (p<0.05) less ability to cry, irritation, care about others' feelings, sadness, erotic dreaming, creativity, surprise, anger, expression of their feelings, worry over things or situations, sexual pleasure, and interest in sex. Total score on the LEIS did not correlate with total score on the Hamilton Depression Rating Scale. In our sample, 80% of patients with SSRI-induced sexual dysfunction also describe clinically significant blunting of several emotions. Emotional blunting may be an under-appreciated side-effect of SSRIs that may contribute to treatment non-compliance and/or reduced quality of life.

Citing Articles

Probing Public Perceptions of Antidepressants on Social Media: Mixed Methods Study.

Zhu J, Zhang X, Jin R, Jiang H, Kenne D JMIR Form Res. 2025; 9:e62680.

PMID: 40009806 PMC: 11882120. DOI: 10.2196/62680.


Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.

Erritzoe D, Barba T, Greenway K, Murphy R, Martell J, Giribaldi B EClinicalMedicine. 2025; 76():102799.

PMID: 39764567 PMC: 11701471. DOI: 10.1016/j.eclinm.2024.102799.


Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments.

De Filippis S, Martinotti G, Nicoletti F, Mastrostefano A, Trovini G, Pugliese A Curr Neuropharmacol. 2024; 23(3):256-275.

PMID: 39219428 PMC: 11808588. DOI: 10.2174/1570159X22666240827165327.


The effect of SSRIs on unconditioned anxiety: a systematic review and meta-analysis of animal studies.

Heesbeen E, van Kampen T, Verdouw P, van Lissa C, Bijlsma E, Groenink L Psychopharmacology (Berl). 2024; 241(9):1731-1755.

PMID: 38980348 PMC: 11339141. DOI: 10.1007/s00213-024-06645-2.


Development of a multivariate prediction model for antidepressant resistant depression using reward-related predictors.

Liu X, Read S Front Psychiatry. 2024; 15:1349576.

PMID: 38590792 PMC: 10999634. DOI: 10.3389/fpsyt.2024.1349576.